Shandong Xinhua Pharmaceutical Co (SZSE:000756) EPS (Basic) : ¥0.63 (TTM As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co EPS (Basic)?

Shandong Xinhua Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥0.15. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.63.

Shandong Xinhua Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥0.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.61.

Shandong Xinhua Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.15. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.69.

During the past 12 months, Shandong Xinhua Pharmaceutical Co's average EPS without NRIGrowth Rate was -13.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 34.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Shandong Xinhua Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 166.80% per year. The lowest was -57.30% per year. And the median was 12.20% per year.

Shandong Xinhua Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co EPS (Basic) Chart

Shandong Xinhua Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.52

0.56

0.62

0.74

0.69

Shandong Xinhua Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.21	0.18	0.11	0.19	0.15

Shandong Xinhua Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shandong Xinhua Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(470.024	-	0)	/	681.194
	=	0.69

Shandong Xinhua Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(112.095	-	0)	/	747.302
	=	0.15

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.63

Shandong Xinhua Pharmaceutical Co (SZSE:000756) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Shandong Xinhua Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Xinhua Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » EPS (Basic)

Traded in Other Exchanges

00719:Hong Kong

Address

No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086

Website

http://www.xhzy.com

Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.

Executives

Wang Xiao Long	Executives
Du De Qing	Executives
Zhang Dai Ming	Director
Cao Zhang Qiu	Secretary Dong
Xu Lie	Director
Wei Zhang Sheng	Executives
He Tong Qing	Directors, executives
Zheng Zhong Hui	Executives
Xu Wen Hui	Executives
Guo Qin	Director
Dou Xue Jie	Executives
Sun Ming Gao	Director
Fu Heng Qian	Executives
Liu Qiang	Supervisors
Gao Qing Gang	Supervisors

Shandong Xinhua Pharmaceutical Co Headlines

No Headlines